Published in Nat Med on September 01, 2001
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer (2006) 8.50
A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A (2004) 5.32
The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell (2010) 5.07
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A (2007) 4.81
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest (2010) 4.70
Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol (2006) 4.32
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov (2009) 4.12
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05
Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell (2010) 3.69
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer (2010) 3.44
Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36
Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet (2005) 3.11
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A (2002) 2.79
Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A (2002) 2.74
Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells (2004) 2.73
Functional and molecular characterisation of mammary side population cells. Breast Cancer Res (2002) 2.63
Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell (2009) 2.57
Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov (2014) 2.55
The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A (2004) 2.53
Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell (2014) 2.44
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer (2003) 2.33
Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med (2013) 2.20
Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol (2002) 2.16
Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A (2002) 2.08
Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol (2005) 2.04
Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J (2005) 2.03
Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol (2007) 2.02
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat (2010) 1.98
ABCG2: a perspective. Adv Drug Deliv Rev (2008) 1.97
The protective role of pregnancy in breast cancer. Breast Cancer Res (2005) 1.95
Multipotent stem cells in human corneal stroma. Stem Cells (2005) 1.95
ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells (2005) 1.95
Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol (2005) 1.93
BRCA1 functions as a breast stem cell regulator. J Med Genet (2004) 1.92
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer (2010) 1.85
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One (2009) 1.82
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood (2011) 1.76
Niche regulation of corneal epithelial stem cells at the limbus. Cell Res (2007) 1.76
Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells. J Cell Sci (2005) 1.75
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer (2011) 1.69
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis (2007) 1.66
Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res (2008) 1.65
TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population. Br J Cancer (2010) 1.65
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology (2011) 1.64
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leuk Lymphoma (2010) 1.64
Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med (2002) 1.63
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer (2012) 1.63
More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther (2010) 1.60
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta (2010) 1.59
Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One (2007) 1.54
Evidence for diversity in transcriptional profiles of single hematopoietic stem cells. PLoS Genet (2006) 1.51
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol (2008) 1.49
Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol (2003) 1.49
Isolation and characterization of functional mammary gland stem cells. Cell Prolif (2003) 1.49
Control of intracellular heme levels: heme transporters and heme oxygenases. Biochim Biophys Acta (2011) 1.48
Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. J Biol Chem (2011) 1.48
Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des (2011) 1.47
Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev (2010) 1.46
Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol (2008) 1.46
Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Dig Dis Sci (2010) 1.45
Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol (2007) 1.45
Identification and targeting of cancer stem cells. Bioessays (2009) 1.44
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents. PLoS One (2015) 1.44
Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes. Cancer Biol Ther (2009) 1.43
Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect (2010) 1.42
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. J Cell Biol (2006) 1.42
Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res (2007) 1.42
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib. Drug Metab Dispos (2010) 1.41
Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog (2010) 1.40
NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat (2007) 1.39
Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci (2011) 1.39
Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med (2007) 1.38
ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch (2006) 1.37
Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J (2009) 1.35
Iron and porphyrin trafficking in heme biogenesis. J Biol Chem (2010) 1.34
Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer (2008) 1.33
Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One (2010) 1.33
Role of stem cells in cardiovascular biology. J Thromb Haemost (2011) 1.31
Musculin/MyoR is expressed in kidney side population cells and can regulate their function. J Cell Biol (2005) 1.31
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res (2008) 1.31
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer (2011) 1.30
Quorum sensing and multidrug transporters in Escherichia coli. Proc Natl Acad Sci U S A (2006) 1.29
Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A (2012) 1.29
Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem (2009) 1.28
Very small embryonic-like stem cells purified from umbilical cord blood lack stem cell characteristics. PLoS One (2012) 1.28
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol (2008) 1.28
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer (2008) 1.27
ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood (2006) 1.27
Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci U S A (2007) 1.27
Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS One (2010) 1.27
Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol (2007) 1.26
Prostate cancer stem cells. J Pathol (2009) 1.26
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol (2006) 1.26
Breast cancer stem cells: implications for therapy of breast cancer. Breast Cancer Res (2008) 1.26
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54
Localization of DNA sequences necessary for transcription of the rabbit beta-globin gene in vitro. Cell (1981) 8.48
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (1996) 5.45
DNA sequences necessary for transcription of the rabbit beta-globin gene in vivo. Nature (1982) 4.97
Age-associated characteristics of murine hematopoietic stem cells. J Exp Med (2000) 4.65
Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (1996) 4.38
Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev (1990) 4.07
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity (1999) 3.53
Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med (1991) 3.48
In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood (1992) 3.15
Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest (1998) 3.15
Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia (2005) 3.13
Sequence requirements for the transcription of the rabbit beta-globin gene in vivo: the -80 region. Nucleic Acids Res (1982) 3.11
Defective lymphoid development in mice lacking Jak3. Science (1995) 3.04
The dose dependence of glucocorticoid-inducible gene expression results from changes in the number of transcriptionally active templates. EMBO J (1990) 3.04
Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther (2001) 2.79
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66
Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology (2000) 2.43
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer. EMBO J (1998) 2.13
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest (1992) 2.11
Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev (1981) 2.11
Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol (2006) 2.06
Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood (1991) 2.02
Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res (1990) 2.01
Presence of hematopoietic stem cells in the adult liver. Nat Med (1996) 2.00
Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood (2000) 1.93
In vitro self-renewal division of hematopoietic stem cells. J Exp Med (2000) 1.91
A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science (1992) 1.90
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity (1999) 1.79
Use of human hepatocytes to study P450 gene induction. Methods Enzymol (1996) 1.79
Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med (1993) 1.75
Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood (2000) 1.74
A role for pref-1 and HES-1 in thymocyte development. J Immunol (2000) 1.70
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J Biol Chem (2001) 1.67
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem (2001) 1.67
P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci U S A (1996) 1.65
Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J Biol Chem (1998) 1.64
Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A (1995) 1.58
Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg (1999) 1.57
A transcription map for the rabbit beta-globin gene. Cell (1981) 1.57
Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood (1989) 1.55
A new information system for medical practice. Arch Intern Med (1975) 1.55
In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J Immunol (1996) 1.55
Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nat Med (1998) 1.54
Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions. Proc Natl Acad Sci U S A (1985) 1.53
Alternative promoters regulate transcription of the mouse GATA-2 gene. J Biol Chem (1998) 1.53
Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet (1990) 1.52
Treatment of idiopathic club foot using the Ponseti method. Initial experience. J Bone Joint Surg Br (2006) 1.52
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol (1996) 1.51
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics (1996) 1.50
Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest (1996) 1.49
The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. Biochemistry (1995) 1.49
The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up. Circulation (1978) 1.48
Correction of hammer toe with an extended release of the metatarsophalangeal joint. J Bone Joint Surg Br (2002) 1.48
A stimulatory effect of recombinant murine interleukin-7 (IL-7) on B-cell colony formation and an inhibitory effect of IL-1 alpha. Blood (1989) 1.48
Activity and expression of murine small Maf family protein MafK. J Biol Chem (1995) 1.46
Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol (2002) 1.42
Simultaneous recording of pattern reversal electroretinograms and visual evoked potentials in migraine. Cephalalgia (1997) 1.41
Efficacy of transthoracic needle aspiration in community-acquired pneumonia. Intern Med (2001) 1.39
Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood (2000) 1.39
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev (1995) 1.37
Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. Science (1994) 1.36
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A (1995) 1.36
MN1 overexpression is an important step in the development of inv(16) AML. Leukemia (2007) 1.35
Risk factors in coronary artery bypass surgery. Arch Surg (1972) 1.33
Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. Mol Ther (2001) 1.33
In vivo selection of retrovirally transduced hematopoietic stem cells. Nat Med (1998) 1.33
Traumatic ventricular septal defect secondary to nonpenetrating chest trauma. Am J Med (1970) 1.33
Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum Mol Genet (1999) 1.31
Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. Arch Intern Med (1997) 1.30
Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharmacol (1998) 1.27
Quinidine excretion in aciduria and alkaluria. Ann Intern Med (1969) 1.27
The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. Circulation (1978) 1.26
6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther (1999) 1.25
Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1. J Biol Chem (1995) 1.24
Variability in human cytochrome P450 paclitaxel metabolism. J Pharmacol Exp Ther (1995) 1.23
Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol Pharmacol (1997) 1.23
Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver. Blood (2000) 1.23
Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci (2002) 1.22
A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev (1999) 1.22
The natural history of right coronary arterial occlusion in the pig. Comparison with left anterior descending arterial occlusion. Am J Cardiol (1970) 1.21
p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A (1997) 1.21
Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. Circulation (1995) 1.20
Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone. J Immunol (1985) 1.19
The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol (2000) 1.18
Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett (1997) 1.18